Patents by Inventor Stefan Baeurle

Stefan Baeurle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12273059
    Abstract: A switch controller coupled to control a transistor. The switch controller comprising an interface coupled to receive a command signal in response to an event sensed in a control system. The command signal is representative of a first command to control the transistor with a first drive strength or a second command to control the transistor with a second drive strength. The switch controller is coupled to adjust a fall time or a rise time, or to adjust both the fall time and the rise time, of a voltage across the transistor in response to the command signal. The fall time or the rise time, or both the fall time and the rise time in response to the second command is shorter than the fall time or the rise time, or both the fall time and the rise time in response to the first command.
    Type: Grant
    Filed: March 30, 2023
    Date of Patent: April 8, 2025
    Assignee: POWER INTEGRATIONS, INC.
    Inventor: Stefan Baeurle
  • Patent number: 12239630
    Abstract: The present invention relates to carboxylic acid aromatic amides compounds of general formula (I) as described and defined herein, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a diseases a sole agent or in combination with other active ingredients.
    Type: Grant
    Filed: April 7, 2023
    Date of Patent: March 4, 2025
    Assignee: BAYER PHARMA AKTIENGESELLSCHAFT
    Inventors: Stefan Baeurle, Adam Davenport, Christopher Stimson, Jens Nagel, Nicole Schmidt, Andrea Rotgeri, Ina Groeticke, Alexandra Rausch, Juergen Klar, Thomas Dyrks
  • Patent number: 11905270
    Abstract: The present invention relates to carboxylic acid aromatic amides compounds of general formula (I) as described and defined herein, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a diseaseas a sole agent or in combination with other active ingredients.
    Type: Grant
    Filed: December 18, 2017
    Date of Patent: February 20, 2024
    Assignee: BAYER PHARMA AKTIENGESELLSCHAFT
    Inventors: Stefan Baeurle, Adam James Davenport, Christopher Stimson, Jens Nagel, Nicole Schmidt, Andrea Rotgeri, Ina Groeticke, Alexandra Rausch, Juergen Klar, Thomas Dyrks
  • Patent number: 11907054
    Abstract: The system comprises a plurality of driver modules coupled by a fault condition bus, e.g. single-wire bus. Each driver module includes an Error Flag Interface block coupled between a single terminal error flag input/output (EF I/O) and a Control block. Each driver module may be coupled- to a motor. When a driver module detects a local fault condition, its Error Flag Interface block is configured to lower the voltage at the single terminal EF I/O to communicate the change to the other driver modules. The Error Flag Interface block is further configured to monitor voltage changes at its single terminal EF I/O. An external fault condition is detected when the single terminal EF I/O is at a low voltage. The Error Flag Interface block is further configured to send a signal disabling the output of the driver module.
    Type: Grant
    Filed: June 21, 2022
    Date of Patent: February 20, 2024
    Assignee: POWER INTEGRATIONS, INC.
    Inventors: Stefan Baeurle, Michael Yue Zhang
  • Publication number: 20230259418
    Abstract: The system comprises a plurality of driver modules coupled by a fault condition bus, e.g. single-wire bus. Each driver module includes an Error Flag Interface block coupled between a single terminal error flag input/output (EF I/O) and a Control block. Each driver module may be coupled- to a motor. When a driver module detects a local fault condition, its Error Flag Interface block is configured to lower the voltage at the single terminal EF I/O to communicate the change to the other driver modules. The Error Flag Interface block is further configured to monitor voltage changes at its single terminal EF I/O. An external fault condition is detected when the single terminal EF I/O is at a low voltage. The Error Flag Interface block is further configured to send a signal disabling the output of the driver module.
    Type: Application
    Filed: June 21, 2022
    Publication date: August 17, 2023
    Applicant: Power Integrations, Inc.
    Inventors: Stefan Baeurle, Michael Yue Zhang
  • Publication number: 20230238909
    Abstract: A switch controller coupled to control a transistor. The switch controller comprising an interface coupled to receive a command signal in response to an event sensed in a control system. The command signal is representative of a first command to control the transistor with a first drive strength or a second command to control the transistor with a second drive strength. The switch controller is coupled to adjust a fall time or a rise time, or to adjust both the fall time and the rise time, of a voltage across the transistor in response to the command signal. The fall time or the rise time, or both the fall time and the rise time in response to the second command is shorter than the fall time or the rise time, or both the fall time and the rise time in response to the first command.
    Type: Application
    Filed: March 30, 2023
    Publication date: July 27, 2023
    Applicant: POWER INTEGRATIONS, INC.
    Inventor: Stefan Baeurle
  • Patent number: 11646689
    Abstract: A control system configured to control a transistor configured to control energy delivery to a load. The control system comprises a system controller to sense an event in the control system and to assert a command signal in response to the sensed event and a switch controller configured to receive the command signal. The switch controller is configured to control the turn on and the turn off of the transistor, wherein the system controller controls the turn on or the turn off, or control both the turn on and the turn off of the transistor with a first drive strength in response to a first command in the command signal and controls the turn on or the turn off, or control both the turn on and the turn off of the transistor with a second drive strength in response to a second command in the command signal.
    Type: Grant
    Filed: February 18, 2021
    Date of Patent: May 9, 2023
    Assignee: POWER INTEGRATIONS, INC.
    Inventor: Stefan Baeurle
  • Publication number: 20210175834
    Abstract: A control system configured to control a transistor configured to control energy delivery to a load. The control system comprises a system controller to sense an event in the control system and to assert a command signal in response to the sensed event and a switch controller configured to receive the command signal. The switch controller is configured to control the turn on and the turn off of the transistor, wherein the system controller controls the turn on or the turn off, or control both the turn on and the turn off of the transistor with a first drive strength in response to a first command in the command signal and controls the turn on or the turn off, or control both the turn on and the turn off of the transistor with a second drive strength in response to a second command in the command signal.
    Type: Application
    Filed: February 18, 2021
    Publication date: June 10, 2021
    Applicant: Power Integrations, Inc.
    Inventor: Stefan Baeurle
  • Patent number: 10998843
    Abstract: A control system to control a conductivity modulated device of a power switching array. The control system comprises a system controller to sense a power event and to output a command signal to adjust a drive characteristic of the conductivity modulated device in response to the sensed power event and a switch controller configured to receive the command signal and to control energy delivery to the load by controlling the turn on and turn off of the conductivity modulated device. The switch controller includes an adjustable drive element to control a rise time and/or fall time of a voltage across the conductivity modulated device and a drive characteristic control to receive the command signal and vary the drive characteristics by control of the adjustable drive element to adjust the rise time and/or fall time of the voltage across the conductivity modulated device in response to the command signal.
    Type: Grant
    Filed: September 23, 2019
    Date of Patent: May 4, 2021
    Assignee: Power Integrations, Inc.
    Inventor: Stefan Baeurle
  • Publication number: 20210091701
    Abstract: A control system to control a conductivity modulated device of a power switching array. The control system comprises a system controller to sense a power event and to output a command signal to adjust a drive characteristic of the conductivity modulated device in response to the sensed power event and a switch controller configured to receive the command signal and to control energy delivery to the load by controlling the turn on and turn off of the conductivity modulated device. The switch controller includes an adjustable drive element to control a rise time and/or fall time of a voltage across the conductivity modulated device and a drive characteristic control to receive the command signal and vary the drive characteristics by control of the adjustable drive element to adjust the rise time and/or fall time of the voltage across the conductivity modulated device in response to the command signal.
    Type: Application
    Filed: September 23, 2019
    Publication date: March 25, 2021
    Applicant: Power Integrations, Inc.
    Inventor: Stefan Baeurle
  • Patent number: 8198456
    Abstract: This invention provides novel dihydropyridine derivatives of the formula I having protein tyrosine kinase inhibitory activity, to process for the manufacture thereof and to the use thereof for the treatment of c-Met-mediated diseases or c-Met-mediated conditions.
    Type: Grant
    Filed: December 13, 2007
    Date of Patent: June 12, 2012
    Assignee: Bayer Intellectual Property GmbH
    Inventors: Marc Adler, Stefan Baeurle, Judi Bryant, Ming Chen, Yuo-Ling Chou, Paul Hrvatin, Seock-Kyu Khim, Monica Kochanny, Wheeseong Lee, Michael Mamounas, Janet Meurer Ogden, Gary Bruce Phillips, Victor Selchau, Christopher West, Bin Ye, Shendong Yuan, Martin Krueger
  • Patent number: 8097627
    Abstract: The invention relates to multiply-substituted tetrahydronaphthalene derivatives of formula (I) process for their production and their use as anti-inflammatory agents.
    Type: Grant
    Filed: December 18, 2009
    Date of Patent: January 17, 2012
    Assignee: Bayer Pharma AG
    Inventors: Hartmut Rehwinkel, Stefan Baeurle, Markus Berger, Norbert Schmees, Heike Schaecke, Konrad Krolikiewicz, Anne Mengel, Duy Nguyen, Stefan Jaroch, Werner Skuballa
  • Publication number: 20100144742
    Abstract: The invention relates to multiply-substituted tetrahydronaphthalene derivatives of formula (I) process for their production and their use as anti-inflammatory agents.
    Type: Application
    Filed: December 18, 2009
    Publication date: June 10, 2010
    Inventors: Hartmut REHWINKEL, Stefan Baeurle, Markus Berger, Norbert Schmees, Heike Schaecke, Konrad Krolikiewicz, Anne Mengel, Duy Nguyen, Stefan Jaroch, Werner Skuballa
  • Patent number: 7662821
    Abstract: The invention relates to tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents.
    Type: Grant
    Filed: October 12, 2004
    Date of Patent: February 16, 2010
    Assignee: Bayer Schering Pharma AG
    Inventors: Hartmut Rehwinkel, Stefan Baeurle, Markus Berger, Norbert Schmees, Heike Schaecke, Konrad Krolikiewicz, Anne Mengel, Duy Nguyen, Stefan Jaroch, Werner Skuballa
  • Patent number: 7659297
    Abstract: The invention relates to multiply-substituted tetrahydronaphthalene derivatives of formula (I) process for their production and their use as antiinflammatory agents.
    Type: Grant
    Filed: October 8, 2004
    Date of Patent: February 9, 2010
    Assignee: Bayer Schering Pharma, AG
    Inventors: Hartmut Rehwinkel, Stefan Baeurle, Markus Berger, Norbert Schmees, Heike Schaecke, Konrad Krolikiewicz, Anne Mengel, Duy Nguyen, Stefan Jaroch, Werner Skuballa
  • Patent number: 7638515
    Abstract: The invention relates to tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents.
    Type: Grant
    Filed: October 12, 2004
    Date of Patent: December 29, 2009
    Assignee: Bayer Schering Pharma Aktiengesellschaft
    Inventors: Hartmut Rehwinkel, Stefan Baeurle, Markus Berger, Norbert Schmees, Heike Schaecke, Konrad Krolikiewicz, Anne Mengel, Duy Nguyen, Stefan Jaroch, Werner Skuballa
  • Publication number: 20090270381
    Abstract: The present invention relates to non-steroidal progesterone receptor modulators of the general formula I, the use of the progesterone receptor modulators for the manufacture of medicaments, and pharmaceutical compositions which comprise these compounds. The compounds according to the invention are suitable for the therapy and prophylaxis of gynecological disorders such as endometriosis, leiomyomas of the uterus, dysfunctional bleeding and dysmenorrhoea, and for the therapy and prophylaxis of hormone-dependent tumours and for use for female fertility control and for hormone replacement therapy.
    Type: Application
    Filed: December 12, 2008
    Publication date: October 29, 2009
    Inventors: Wolfgang SCHWEDE, Thomas Andrew Kirkland, Carsten Moeller, Stefan Baeurle, Ralf Wyrwa, Andrea Rotgeri
  • Patent number: 7442794
    Abstract: The invention relates to the compounds of formula I, a process for their production and their use as anti-inflammatory agents.
    Type: Grant
    Filed: October 8, 2004
    Date of Patent: October 28, 2008
    Assignee: Schering AG
    Inventors: Hartmut Rehwinkel, Stefan Baeurle, Markus Berger, Norbert Schmees, Heike Schaecke, Konrad Krolikiewicz, Anne Mengel, Duy Nguyen, Stefan Jaroch, Werner Skuballa
  • Publication number: 20080176833
    Abstract: This invention provides novel dihydropyridine derivatives of the formula I having protein tyrosine kinase inhibitory activity, to process for the manufacture thereof and to the use thereof for the treatment of c-Met-mediated diseases or c-Met-mediated conditions.
    Type: Application
    Filed: December 13, 2007
    Publication date: July 24, 2008
    Inventors: Marc Adler, Stefan Baeurle, Judi Bryant, Ming Chen, Yuo-Ling Chou, Paul Hrvatin, Seock-Kyu Khim, Monica Kochanny, Wheeseong Lee, Michael Mamounas, Janet Meurer Ogden, Gary Bruce Phillips, Victor Selchau, Christopher West, Bin Ye, Shendong Yuan, Martin Krueger
  • Publication number: 20080153859
    Abstract: The invention relates to multiply-substituted tetrahydronaphthalene derivatives of formula (I) process for their production and their use as anti-inflammatory agents.
    Type: Application
    Filed: February 25, 2008
    Publication date: June 26, 2008
    Inventors: Hartmut Rehwinkel, Stefan Baeurle, Markus Berger, Norbert Schmees, Heike Schaecke, Konrad Krolikiewicz, Anne Mengel, Duy Nguyen, Stefan Jaroch, Werner Skuballa